oleanolic acid has been researched along with oseltamivir in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Fang, XM; Ji, S; Li, RY; Liang, LN; Si, L; Song, W; Wang, H; Ye, M; Yu, LY; Zhou, D | 1 |
Li, W; Liu, Z; Shen, L; Tao, K; Wang, X; Xie, J; Xu, J; Zhang, R; Zhao, J | 1 |
3 other study(ies) available for oleanolic acid and oseltamivir
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Dogs; Drugs, Chinese Herbal; Glycyrrhiza uralensis; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oleanolic Acid; Oseltamivir; Plant Roots; Saponins | 2014 |
Molecular docking of potential inhibitors for influenza H7N9.
Topics: Antiviral Agents; Cell Line; Chlorogenic Acid; Flavanones; Humans; Hydrogen Bonding; Influenza A Virus, H7N9 Subtype; Molecular Docking Simulation; Neuraminidase; Oleanolic Acid; Oseltamivir; Protein Binding; Quercetin; Software | 2015 |